Cationic polypeptides in a concept of oppositely charged polypeptides as prevention of postsurgical intraabdominal adhesions

Karolin Isaksson, Daniel Åkerberg, Katarzyna Said, Bobby Tingstedt

.

DOI: 10.4236/jbise.2011.43028                

Abstract

Background: Two differently charged polypeptides, α-poly-L-lysine and poly-L-glutamate, have previously been shown to effectively reduce postoperative intraabdominal adhesions. Though α-poly-L-lysine showed toxicity in doses too close to the lowest therapeutic dose, the aim in the present study was to investigate the possible antiadhesive effect of another four cationic polypeptides. Materials/Methods: 125 mice were studied with a standardized and reproducible adhesion model and given epsilon poly-L-lysine, lactoferrin, lysozyme and polyarginine respectively in a combination with poly-L-glutamate. Epsilon poly-L-lysine was also tested in different concentrations and as single treatment. Results: All four cationic polypeptides above showed a significantly better anti-adhesive effect than the controls receiving saline (p<0.05). Epsilon poly-L-lysine had the best antiadhesive effect of the new substances tested in the experiment. Single treatment with the epsilon poly-L-lysine showed toxic side effects. Discussion: We have shown that epsilon poly-L-lysine, polyarginine, lysozyme and lactoferrin, in descending order, all can reduce postoperative intraabdominal adhesions in mice when combined with poly-L-glutamate. There were side effects of epsilon poly-L-lysine resembling those of α-poly-L-lysine, although less toxic. The antiadhesive effect of epsilon poly-L-lysine did not reach the level of α-poly-L-lysine. Further studies will concentrate on additional investigation, trying to modify the α-poly-L-lysine to lower its toxicity. The less toxic epsilon poly-L-lysine also needs further attention in our research of antiadhesive bioactive polypeptides.

Keywords

Postoperative adhesions, bioactive polypeptides, molecular structure

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Ellis, H., Moran, B.J., Thompson, J.N., Parker, M.S., Wilson, M.S. et al. (1999) Adhesion-related hospital readmissions after abdominal and pelvic surgery: A retrospective cohort study. Lancet, 353, 1476-1480. doi:10.1016/S0140-6736(98)09337-4
[2]	Menzies, D. and Ellis, H. (1990) Intestinal obstruction from adhesions--how big is the problem? Annals of The Royal College of Surgeons of England, 72, 60-63.
[3]	Tingstedt, B., Andersson, E., Isaksson, K. and Andersson, R. (2008) Clinical impact of abdominal adhesions: What is the magnitude of the problem? Scandinavian Journal of Gastroenterology, 43, 255-261. doi:10.1080/00365520701708626
[4]	Tingstedt, B., Isaksson, J. and Andersson, R. (2007) Long-term follow-up and cost analysis following surgery for small bowel obstruction caused by intra-abdominal adhesions. British Journal of Surgery, 94, 743-748. doi:10.1002/bjs.5634
[5]	Tingstedt, B., Isaksson, K., Andersson, E. and Andersson, R. (2007) Prevention of abdominal adhesions--present state and what’s beyond the horizon? European Surgical Research, 39, 259- 268. doi:10.1159/000102591
[6]	Johns, D.B., Rodgers, K.E., Donahue, W.D., Kiorpes, T.C. and diZerega, G.S. (1997) Reduction of adhesion formation by post-operative administration of ionically cross-linked hyaluronic acid. Fertility and Sterility, 68, 37-42. doi:10.1016/S0015-0282(97)81472-0
[7]	diZerega, G.S., Verco, S.J., Young, P., Kettel, M., Kobak, W.A., Martin, D. et al. (2002) A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynaecological surgery. Human Reproduction, 17, 1031-1038. doi:10.1093/humrep/17.4.1031
[8]	Muller, S.A., Treutner, K.H., Tietze, L., Anurov, M., Titkova, S., Polivoda, M. et al. (2001) Efficacy of adhesion prevention and impact on wound healing of intraperitoneal phospholipids. Journal of Surgical Research, 96, 68-74. doi:10.1006/jsre.2000.6031
[9]	Nehez, L., Tingstedt, B., Vodros, D., Axelsson, J., Lindman, B. and Andersson, R. (2006) Novel treatment in peritoneal adhesion prevention: protection by polypeptides. Scandinavian Journal of Gastroenterology, 41, 1110-1117. doi:10.1080/00365520600554550
[10]	Tingstedt, B., Nehez, L., Axelsson, J., Lindman, B. and Andersson, R. (2006) Increasing anastomosis safety and preventing abdominal adhesion formation by the use of polypeptides in the rat. International Journal of Colorectal Disease, 21, 566-572. doi:10.1007/s00384-005-0053-x
[11]	Tingstedt, B., Nehez, L., Lindman, B. and Andersson, R. (2007) Efficacy of bioactive polypeptides on bleeding and intra-abdominal adhesions. European Surgical Research, 39, 35-40. doi:10.1159/000098438
[12]	Nehez, L., Vodros, D., Axelsson, J., Tingstedt, B., Lindman, B. and Andersson, R. (2005) Prevention of postoperative peritoneal adhesions: Effects of lysozyme, polylysine and polyglutamate versus hyaluronic acid. Scandinavian Journal of Gastroenterology, 40, 1118-1123. doi:10.1080/00365520510023332
[13]	Isaksson, K., ?kerberg, D., Andersson, R. and Tingstedt, B. (2009) Toxicity and dose response of intra-abdominally administered poly-L-alpha-lysine and poly-L-glutamate for post-operative adhesion protection. European Surgical Research, 44, 17-22. doi:10.1159/000258654
[14]	Holmdahl, L., Al-Jabreen, M. and Risberg, B. (1994) Experimental models for quantative studies on adhesion formation in rats and rabbits. European Journal of Surgery, 26, 248-56. doi:10.1159/000129342
[15]	King, A., Strand, B., Rokstad, A.M., Kulseng, B., Andersson, A. et al. (2003) Improvement of the biocompatibility of alginate/poly-L-lysine/alginate microcapsules by the use of epimerized alginate as a coating. Journal of Biomedical Materials Research A, 64, 533-539. doi:10.1002/jbm.a.10276
[16]	Takei, Y., Maruyama, A., Ferdous, A., Nishimura, Y., Kawano, S., Ikeijima, K. et al. (2004) Targeted gene delivery to sinusoidal endothelial cells: DNA nanoassociate bearing hyaluronanglycocalyx. The FASEB Journal, 18, 699-701.
[17]	Geornaras, I., Yoon, Y., Belk, K.E., Smith, G.C. and Sofos, J.N. (2007) Antimicrobial activity of epsilon-polylysine against Escherichia coli O157:H7, Salmonella Typhimurium, and Listeria monocytogenes in various food extracts. Journal of Food Science, 72, M330-334. doi:10.1111/j.1750-3841.2007.00510.x
[18]	Billinger, M., Buddeberg, F., Hubbell, J.A., Elbert, D.L., Schaffner, T., Mettler, D. et al. (2006) Polymer stent coating for prevention of neointimal hyperplasia. Journal of Invasive Cardiology, 18, 423-426.
[19]	Li, C., Yu, D.F., Newman, R.A., Cabral, F., Stephens, L.C., Hunter, N. et al. (1998) Complete regression of well-established tumors using a novel water-soluble poly-(L-glutamic acid)-paclitaxel conjugate. Cancer Research, 58, 2404-2409.
[20]	Moroson, H. (1971) Polycation-treated tumor cells in vivo and in vitro. Cancer Research, 31, 373-380.
[21]	Shih, I.L., Van, Y.T. and Shen, M.H. (2004) Biomedical applications of chemically and microbiologically synthesized poly (glutamic acid) and poly(lysine). Mini Reviews in Medicinal Chemistry, 4, 179-188. doi:10.2174/1389557043487420
[22]	Larsson, K. (1994) Lipids-molecular organizations, physical functions and technical applications. The Oily Press, Dundee, Scotland.
[23]	Tingstedt, B., Nehez, L., Lindman, B. and Andersson, R. (2007) Effect of bioactive polypeptides on leaking large bowel anastomosis and intestines in the rat. Journal of Investigative Surgery, 20, 229-235. doi:10.1080/08941930701481288
[24]	Morgan, D.M., Larvin, V.L. and Pearson, J.D. (1989) Biochemical characterisation of polycation-induced cytotoxicity to human vascular endothelial cells. Journal of Cell Science, 94, 553-559.
[25]	Moreau, E., Domurado, M., Chapon, P., Vert, M. and Domurad, D. (2002) Biocompatibility of polycations: In vitro agglutination and lysis of red blood cells and in vivo toxicity. Journal of Drug Targeting, 10, 161-173. doi:10.1080/10611860290016766
[26]	Sela, M. and Katchalski, E. (1959) Biological properties of poly-alpha-amino acids. Advances in Protein Chemistry, 14, 391-478. doi:10.1016/S0065-3233(08)60614-2
[27]	Kenausis, G., Voros, J., Elbert, D., Huang, N., Hofer, R., Riuz-Taylor, L. et al. (2000) Poly(l-lysine)-g-Poly-(ethy- lene glycol) layers on metal oxide surfaces: Attachment mechanism and effects of polymer architecture on resistance to protein adsorption. The Journal of Physical Chemistry B, 104, 3298- 3309. doi:10.1021/jp993359m
[28]	Andrews, D.W. and Ottensmeyer, F.P. (1982) Electron microscopy of the poly-L-lysine alpha-helix. Ultramicro- scopy, 9, 337-348. doi:10.1016/0304-3991(82)90094-8
[29]	Chittchang, M., Salamat-Miller, N., Alur, H.H., VanderVelde, D.G., Mitra, A.K. and Johnston, T.P. (2002) Poly(L-lysine) as a model drug macromolecule with which to investigate secondary structure and membrane transport, part I: Physicochemical and stability studies. Journal of Pharmacy and Pharmacology, 54, 315-323. doi:10.1211/0022357021778556
[30]	Fischer, D., Li. Y., Ahlemeyer, B., Kriegelstein, J. and Kissel, T. (2003) In vitro cytotoxicity testing of polycations: Influence of polymer structure on cell viability and hemolysis. Biomaterials, 24, 1121-1131. doi:10.1016/S0142-9612(02)00445-3
[31]	Lv, H., Zhang, S., Wang, B., Cui, S. and Yan, J. (2006) Toxicity of cationic lipids and cationic polymers in gene delivery. Journal of Controlled Release, 114, 100-109. doi:10.1016/j.jconrel.2006.04.014
[32]	Shih, I.L., Shen, M.H. and Van, Y.T. (2004) Microbial synthesis of poly(ε-lysine) and its various applications. Bioresource Technology, 97, 1148-1159. doi:10.1016/j.biortech.2004.08.012
[33]	Szende, B., Szokan, G., Tyiha, E., Pal, K., Gaborjanyi, R., Akmas, M. et al. (2002) Antitumor effect of lysine- isopeptides. Cancer Cell International, 2, 4. doi:10.1186/1475-2867-2-4
[34]	Fuchs, S.M. and Raines, R.T. (2004) Pathway for polyarginine entry into mammalian cells. Biochemistry, 43, 2438-2444. doi:10.1021/bi035933x
[35]	Steijns, J.M. and van Hooijdonk, A.C. (2000) Occurrence, structure, biochemical properties and technological characteristics of lactoferrin. British Journal of Nutrition, 84, S11-17. doi:10.1017/S0007114500002191